|Bid||53.79 x 900|
|Ask||54.09 x 900|
|Day's Range||53.49 - 54.25|
|52 Week Range||39.05 - 60.69|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||16.16|
|Forward Dividend & Yield||1.94 (3.61%)|
|Ex-Dividend Date||Dec 31, 2020|
|1y Target Est||N/A|
Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail independent, small chains and long-term care pharmacy customers to participate in the vaccination effort. The COVID-19 vaccine will be distributed by the CDC's central distributor.
Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2021 revenues of $39.1 billion, an increase of 5% from the first quarter of last year. First quarter GAAP operating loss was $624 million due to a $1.0 billion pre-tax accrual related to opioid litigation. This quarter's accrual is incremental to the $5.6 billion accrual recorded in the first quarter of fiscal year 2020. Non-GAAP operating earnings increased 7% to $618 million in the quarter. GAAP diluted loss per share was $0.86, and non-GAAP diluted earnings per share (EPS) increased 19% to $1.51. These results include a moderate negative impact from COVID-19, primarily concentrated in the Pharmaceutical segment.
Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2021 on November 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.